News | April 23, 2022
IOL Chemicals and Pharmaceuticals commences commercial production of paracetamol
All the capex is being met through internal accruals only
All the capex is being met through internal accruals only
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The new facility is scheduled to start operation in the first half of 2024
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The phosphine ligand is available on the kilo scale for the first time, providing scientists with a powerful solution for cross-coupling chemistry
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
Subscribe To Our Newsletter & Stay Updated
